<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://moneyweek.com/feed/all</title><link>https://moneyweek.com/feed/all</link><description>Individual feed output.</description><lastBuildDate>Mon, 26 Jan 2026 06:35:01 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Michael Moritz: the richest Welshman to walk the Earth</title><link>https://moneyweek.com/people/michael-moritz-the-richest-welshman-to-walk-the-earth</link><image_url>https://cdn.mos.cms.futurecdn.net/tTkDfhVWKfXTcvBBkkJMoP-1280-80.jpg</image_url><description>Michael Moritz started out as a journalist before catching the eye of a Silicon Valley titan. He finds Donald Trump to be “an absurd buffoon”</description><pubDate>Mon, 26 Jan 2026 08:30:00 GMT</pubDate></item><item><title>Three promising emerging-market stocks to diversify your portfolio</title><link>https://moneyweek.com/investments/emerging-markets/emerging-market-stocks-to-diversify-your-portfolio</link><image_url>https://cdn.mos.cms.futurecdn.net/3w5oWX53rotDPpyRcQdQ2T-1280-80.jpg</image_url><description>Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money</description><pubDate>Mon, 26 Jan 2026 07:45:00 GMT</pubDate></item><item><title>Coface offers excess profit in an unloved sector</title><link>https://moneyweek.com/investments/stocks-and-shares/coface-trade-credit-insurance</link><image_url>https://cdn.mos.cms.futurecdn.net/hva3PdCQT3wP3GUf2Uwg8K-1280-80.jpg</image_url><description>Coface is a world leader in trade-credit insurance with key competitive advantages in a niche market</description><pubDate>Mon, 26 Jan 2026 07:00:00 GMT</pubDate></item><item><title>Exciting opportunities in biotech</title><link>https://moneyweek.com/investments/biotech-stocks/biotech-investment-opportunities</link><image_url>https://cdn.mos.cms.futurecdn.net/C5Jc3wJ3deST2tb83ARxkG-1280-80.jpg</image_url><description>Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions</description><pubDate>Sun, 25 Jan 2026 08:30:00 GMT</pubDate></item><item><title>How to invest in the new breed of payment providers</title><link>https://moneyweek.com/investments/invest-in-payment-providers</link><image_url>https://cdn.mos.cms.futurecdn.net/qiMcTsoZaQX7adDxzP4PaH-1280-80.jpg</image_url><description>Upstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves</description><pubDate>Sun, 25 Jan 2026 07:45:00 GMT</pubDate></item></channel></rss>